{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T02:09:01Z","timestamp":1768442941966,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jtct.2023.08.010","type":"journal-article","created":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T12:04:49Z","timestamp":1691928289000},"page":"707.e1-707.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Incidence of Bloodstream Infections after Hematopoietic Stem Cell Transplantation for Hurler Syndrome"],"prefix":"10.1016","volume":"29","author":[{"given":"Chloe","family":"Dunseath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabby","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9939-5854","authenticated-orcid":false,"given":"Sheetal","family":"Mahulkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7916-9022","authenticated-orcid":false,"given":"Priscila","family":"Badia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1858-2881","authenticated-orcid":false,"given":"Jane","family":"Koo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher E.","family":"Dandoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.08.010_bib0001","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.3390\/cells9081838","article-title":"Mucopolysaccharidosis type I: a review of the natural history and molecular pathology","volume":"9","author":"Hampe","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jtct.2023.08.010_bib0002","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11011-012-9302-1","article-title":"Mucopolysaccharidosis type I: current knowledge on its pathophysiological mechanisms","volume":"27","author":"Campos","year":"2012","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.jtct.2023.08.010_bib0003","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.4103\/ijo.IJO_425_22","article-title":"Mucopolysaccharidosis: a broad review","volume":"70","author":"Nagpal","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jtct.2023.08.010_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10545-013-9613-3","article-title":"Mucopolysaccharide diseases: a complex interplay between neuroinflammation, microglial activation, and adaptive immunity","volume":"37","author":"Archer","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jtct.2023.08.010_bib0005","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/gim.2014.25","article-title":"The natural history of MPS I: global perspectives from the MPS I Registry","volume":"16","author":"Beck","year":"2014","journal-title":"Genet Med"},{"key":"10.1016\/j.jtct.2023.08.010_bib0006","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13023-017-0583-7","article-title":"Early disease progression of Hurler syndrome","volume":"12","author":"Kiely","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jtct.2023.08.010_bib0007","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3390\/biom11020189","article-title":"Mucopolysaccharidosis type I: current treatments, limitations, and prospects for improvement","volume":"11","author":"Hampe","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.jtct.2023.08.010_bib0008","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jpeds.2008.11.005","article-title":"Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapy","volume":"154","author":"Wynn","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.jtct.2023.08.010_bib0009","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13023-020-01644-w","article-title":"Long-term disease burden post-transplantation: three decades of observations in 25 Hurler patients successfully treated with hematopoietic stem cell transplantation (HSCT)","volume":"16","author":"Guffon","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jtct.2023.08.010_bib0010","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ymgme.2017.05.009","article-title":"Incomplete biomarker response in mucopolysaccharidosis type I after successful hematopoietic cell transplantation","volume":"122","author":"Kuiper","year":"2017","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jtct.2023.08.010_bib0011","doi-asserted-by":"crossref","first-page":"11724","DOI":"10.3390\/ijms231911724","article-title":"Pathogenic roles of heparan sulfate and its use as a biomarker in mucopolysaccharidoses","volume":"23","author":"Minami","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtct.2023.08.010_bib0012","doi-asserted-by":"crossref","first-page":"e27388","DOI":"10.1002\/pbc.27388","article-title":"Multiple bloodstream infections in pediatric stem cell transplant recipients: a case series","volume":"65","author":"Grossmann","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2023.08.010_bib0013","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/bmt.2017.14","article-title":"Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis","volume":"52","author":"Dandoy","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.010_bib0014","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.18668","article-title":"Incidence, risk factors, and outcomes of patients who develop mucosal barrier injury-laboratory confirmed bloodstream infections in the first 100 days after allogeneic hematopoietic stem cell transplant","volume":"3","author":"Dandoy","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jtct.2023.08.010_bib0015","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/s41409-018-0401-4","article-title":"Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation","volume":"54","author":"Ustun","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.010_bib0016","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/sj.bmt.1703015","article-title":"Engraftment syndrome following hematopoietic stem cell transplantation","volume":"27","author":"Spitzer","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.010_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/bloodadvances.2020003455","article-title":"A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant","volume":"5","author":"Dandoy","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.08.010_bib0018","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.bbmt.2015.06.016","article-title":"Histologic features of intestinal thrombotic microangiopathy in pediatric and young adult patients after hematopoietic stem cell transplantation","volume":"21","author":"El-Bietar","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.010_bib0019","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.08.010_bib0020","year":"2023","journal-title":"Bloodstream infection event"},{"key":"10.1016\/j.jtct.2023.08.010_bib0021","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.bbmt.2016.06.002","article-title":"Healthcare burden, risk factors, and outcomes of mucosal barrier injury laboratory-confirmed bloodstream infections after stem cell transplantation","volume":"22","author":"Dandoy","year":"2016","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723014677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723014677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:09:17Z","timestamp":1763003357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636723014677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2666636723014677"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.08.010","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of Bloodstream Infections after Hematopoietic Stem Cell Transplantation for Hurler Syndrome","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}